About the Authors

Helene Arentz-Hansen, Burkhard Fleckenstein, Øyvind Molberg, Knut E. A Lundin, Ludvig M Sollid
Institute of Immunology, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway

Burkhard Fleckenstein, Peter Roepstorff
Department of Biochemistry and Molecular Biology, University of Southern Denmark, Odense, Denmark

Helge Scott
Institute of Pathology, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway

Frits Koning
Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, Netherlands

Günther Jung
Institute of Organic Chemistry, University of Tbingen, T, Germanyübingen

Knut E. A Lundin
Department of Medicine, Rikshospitalet University Hospital, Oslo, Norway

Corresponding Author

l.m.sollid@labmed.uio.no

Competing Interests

The authors have declared that no competing interests exist. LMS is a member of the editorial board of PLoS Medicine.

Author Contributions

ØM, KEAL, and LMS designed the study. HAH, BF, ØM, HS, FK, GJ, PR, KEAL, and LMS analyzed the data. FK and GJ contributed synthetic peptides for the study. HAH, BF, ØM, HS, FK, GJ, KEAL, and LMS contributed to writing the paper.